Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest

American Journal of Medicine

Volumn 113, Issue 9, 2002, Pages 711-716

  Lemaitre, Rozenn N ^a   Siscovick, David S ^a   Psaty, Bruce M ^a   Pearce, Rachel M ^a   Raghunathan, Trivellore E ^a   Whitsel, Eric A ^a   Weinmann, Sheila A ^a   Anderson, Gail D ^a   Lin, Danyu ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; IPRATROPIUM BROMIDE; STEROID; THEOPHYLLINE;

ADULT; AGE; AGED; ARTICLE; ASTHMA; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HEART ARREST; HEART DISEASE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METERED DOSE INHALER; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; RISK FACTOR; SEX;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; CASE-CONTROL STUDIES; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HEART ARREST; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS;

EID: 0037115694     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01384-0     Document Type: Article

References (20)

1. Guidelines for the Diagnosis and Management of Asthma: Expert Report Panel No. 2. Bethesda, MD: National Heart, Lung, and Blood Institute; 1997.
2. Diette G.B., Wu A.W., Skinner E.A., et al. Treatment patterns among adult patients with asthma. Factors associated with overuse of beta-agonists and underuse of inhaled corticosteroids. Arch Intern Med. 159:1999;2697-2704.
3. Bennett A., Tattersfield A.E. Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax. 52:1997;458-464.
4. Lipworth B.J., McDevitt D.G. Inhaled beta 2-adrenoceptor agonists in asthma help or hindrance? Br J Clin Pharmacol. 33:1992;129-138.
5. Wong C.S., Pavord I.D., Williams J., et al. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet. 336:1990;1396-1399.
6. Jouve X., Desnos M., Guerot C., Ducimetiere P. Predicting sudden death in the population the Paris Prospective Study I . Circulation. 99:1999;1978-1983.
7. de Bruyne M.C., Hoes A.W., Kors J.A., et al. QTc dispersion predicts cardiac mortality in the elderly the Rotterdam Study . Circulation. 97:1998;467-472.
8. Manttari M., Oikarinen L., Manninen V., Viitasalo M. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart. 78:1997;268-272.
9. Copie X., Hnatkova K., Staunton A., et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol. 27:1996;270-276.
10. Siegel D., Hulley S.B., Black D.M., et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 267:1992;1083-1089.
11. Olsson S.B. Nature of cardiac arrhythmias and electrolyte disturbances. Role of potassium in atrial fibrillation. Acta Med Scand Suppl. 647:1981;33-37.
12. Fisch C. Relation of electrolyte disturbances to cardiac arrhythmias. Circulation. 47:1973;408-419.
13. Kendall M.J., Lynch K.P., Hjalmarson A., Kjekshus J. Beta-blockers and sudden cardiac death. Ann Intern Med. 123:1995;358-367.
14. Spitzer W.O., Suissa S., Ernst P., et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 326:1992;501-506.
15. Suissa S., Blais L., Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J. 7:1994;1602-1609.
16. Pearce N., Hensley M.J. Epidemiologic studies of beta agonists and asthma deaths. Epidemiol Rev. 20:1998;173-186.
17. Suissa S., Hemmelgarn B., Blais L., Ernst P. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med. 154:1996;1598-1602.
18. Robinson D.S., Geddes D.M. Inhaled corticosteroids benefits and risks . J Asthma. 33:1996;5-16.
19. Donahue J.G., Weiss S.T., Livingston J.M., et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 277:1997;887-891.
20. Kerstjens H.A., Brand P.L.M., Hughes M.D., et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med. 37:1992;1413-1419.